Author

Rebeca Martínez-Turrillas

Centro de Investigación Biomédica en Red de CáncerORCID 0000-0003-1013-7898Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:scRNA-seq· 2 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Felipe PrósperiD· 2 shared Juan José LasarteiD· 2 shared Juan R. Rodríguez-MadoziD· 2 shared María Eréndira Calleja-CervantesiD· 2 shared Mikel HernáeziD· 2 shared Patxi San Martín‐ÚriziD· 2 shared Paula Aguirre-RuiziD· 2 shared Saray Rodríguez-DiaziD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Felipe PrósperORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintJun 5, 2026

Rational engineering of sdAb-based CAR T cells targeting BCMA enhances antitumor efficacy and persistence in Multiple Myeloma

Vianca Ibarra-Garcia, María Eréndira Calleja-Cervantes, Federica Rochira…·Felipe Prósper

This study engineers sdAb-based CAR T cells targeting BCMA, showing improved antitumor efficacy and persistence in multiple myeloma compared to existing therapies.

DOI 10.64898/2026.06.02.729637

humanscRNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintMay 3, 2026

Rapid and dynamic reprogramming within the tumor microenvironment drives EDA-CAR-T dysfunction and compromised therapeutic efficacy in solid tumors

Rodrigo A Redondo-Frutos, Pedro Justicia-Lirio, María Eréndira Calleja-Cervantes…·Juan R. Rodríguez-Madoz

This study uses single-cell RNA sequencing to analyze EDA-CAR-T cell dynamics in the tumor microenvironment, revealing temporal reprogramming toward dysfunction and identifying immunosuppressive pathways that impair therapeutic efficacy in solid tumors.

DOI 10.64898/2026.04.29.721801

mousescRNA-seq

𝕏 PostBluesky